切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 231 -233. doi: 10.3877/cma.j.issn.2095-3216.2018.05.009

所属专题: 指南与规范 文献 指南共识

综述

日本血管通路2015指南解读
刘佳玮1, 王荣2, 武杏1, 伍刚1,()   
  1. 1. 116023 辽宁省,大连医科大学;225001 江苏省,扬州大学临床医学院 江苏省苏北人民医院
    2. 225001 江苏省,扬州大学临床医学院 江苏省苏北人民医院
  • 收稿日期:2018-03-28 出版日期:2018-10-28
  • 通信作者: 伍刚

Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications

Jiawei Liu1, Rong Wang2, Xing Wu1, Gang Wu1,()   

  1. 1. Dalian Medical University, Dalian 116023, Liaoning Province; Jiangsu Provincial Subei People′s Hospital, Yangzhou University Clinical Medical College, Yangzhou 225001, Jiangsu Province; China
    2. Jiangsu Provincial Subei People′s Hospital, Yangzhou University Clinical Medical College, Yangzhou 225001, Jiangsu Province; China
  • Received:2018-03-28 Published:2018-10-28
  • Corresponding author: Gang Wu
  • About author:
    Corresponding author: Wu Gang, Email:
引用本文:

刘佳玮, 王荣, 武杏, 伍刚. 日本血管通路2015指南解读[J]. 中华肾病研究电子杂志, 2018, 07(05): 231-233.

Jiawei Liu, Rong Wang, Xing Wu, Gang Wu. Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(05): 231-233.

随着患者生存率的逐年增高、老龄化、慢性病患者和糖尿病肾病患者的增加,血管通路耗竭的情况越来越常见,血管通路的建立及其修复也越来越困难;血管通路、移植物血管通路及动脉浅表化穿刺的建立及其并发症的预防、处理策略,将会成为影响血液透析水平的重要因素。本文就日本血管通路指南中移植物血管通路(AVG)、动脉浅表化建立及围手术期管理做一概述。

With the increases of patient survival rate, aging, chronic disease and diabetic nephropathy, the depletion of vascular access is becoming more common, and the establishment and repair of vascular access are becoming more and more difficult. The establishment of vascular access, graft vascular access, and superficial arterial puncture as well as the prevention and treatment strategies of complications will become important factors affecting the level of hemodialysis. This article provided an overview of the arteriovenous grafts (AVG) access, the establishment of arteries superficialization, and perioperative management according to the Japanese 2015 guidelines for vascular access.

图1 移植物血管通路插管部位感染处理流程图
表1 动脉浅表化手术适应症[1]
[1]
Kukita K, Ohira S, Amano I, et al. 2011 update Japanese Society for Dialysis Therapy guidelines of vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2015, 19 (Suppl 1): 1-39.
[2]
Akoh J. Prosthetic arteriovenous grafts for hemodialysis [J]. J Vasc Access, 2009, 10(3): 137-147.
[3]
Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis [J]. Am J Surg, 1986, 152(2): 238-243.
[4]
Ota K, Tsuji Y, Kukita K. Long-term outcome of Terumo vascular graft (GRASIL®) for hemodialysis [J]. J Jpn Soc Dial Ther, 2006, 39: 1395-1401.
[5]
Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency [J]. N Engl J Med, 2009, 360(21): 2191-2201.
[6]
Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts [J]. Surgery, 1985, 97(2): 194-204.
[7]
Gargiulo NR, Veith FJ, Scher LA, et al. Experience with covered stents for the management of hemodialysis polytetrafluoroethylene graft seromas [J]. J Vasc Surg, 2008, 48(1): 216-217.
[8]
Dauria DM, Dyk P, Garvin P. Incidence and management of seroma after arteriovenous graft placement [J]. J Am Coll Surg, 2006, 203(4): 506-511.
[9]
Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis [J]. Kidney Int, 1999, 55(3): 1081-1090.
[10]
Amano I, Ohira S, Goto Y, et al. In preparation for a treatment guideline for suitable vascular access repair in Japan [J]. Ther Apher Dial, 2006, 10(4): 364-371.
[11]
D′Cunha PT, Besarab A. Vascular access for hemodialysis: 2004 and beyond [J]. Curr Opin Nephrol Hypertens, 2004, 13(6): 623-629.
[12]
Glickman M, Stokes G, Ross J. Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications [J]. J Vasc Surg, 2001, 34(3): 465-473.
[13]
Sakka SG, Reinhart K, Wegscheider K, et al. Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients [J]. Chest, 2002, 121(2): 559-565.
[14]
Earley A, Persson R, Raman G. III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000 [J]. Am J Kidney Dis, 2001, 37(1 Suppl 1): S137-S181.
[15]
Turmel-Rodrigues L, Pengloan J, Blanchier D. Insufficient dialysis shunts: improved long term patency rates with close hemodynamic monitering, repeated percutaneous balloon angioplasty, and stent placement [J]. Radiology, 1993, 187: 273-278.
[16]
Degawa H, Tagawa H, Tomikawa S. Long-term outcome of expanded polytetrafluoroethylene graft for hemodialysis access [J]. J Jpn Soc Dial Ther, 1995, 28: 1359-1365.
[17]
Bhatia DS, Money SR, Ochsner JL, et al. Comparison of surgical bypass and percutaneous balloon dilatation with primary stent placement in the treatment of central venous obstruction in the dialysis patient: one-year follow-up [J]. Ann Vasc Surg, 1996, 10(5): 452-455.
[18]
Kovalik EC, Newman GE, Suhocki P, et al. Correction of central venous stenoses: use of angioplasty and vascular Wallstents [J]. Kidney Int, 1994, 45(4): 1177-1181.
[19]
Poulain F, Raynaud A, Bourquelot P, et al. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas [J]. Cardiovasc Intervent Radiol, 1991, 14(2): 98-101.
[20]
Gmelin E, Winterhoff R, Rinast E. Insufficient hemodialysis access fistulas: late results of treatment with percutaneous balloon angioplasty [J]. Radiology, 1989, 171(3): 657-660.
[21]
Trerotola SO, Davidson DD, Filo RS, et al. Preclinical in vivo testing of a rotational mechanical thrombolytic device [J]. J Vasc Interv Radiol, 1996, 7(5): 717-723.
[22]
Ohira S, Naito H, Amano I, et al. 2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2006, 10(5): 449-462.
[23]
National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative. Clinical practice guidelines for vascular access [J]. Am J Kidney Dis, 1997, 30(4 Suppl 3): S150-S191.
[1] 金鑫, 谢卯, 刘芸, 杨操, 杨述华, 许伟华. 个性化股骨导向器辅助初次全髋关节置换的随机对照研究[J]. 中华关节外科杂志(电子版), 2023, 17(06): 780-787.
[2] 易晨, 张亚东, 董茜, 唐海阔, 刘志国. 应用骨盖技术拔除下颌低位骨性埋伏阻生第三磨牙的疗效观察[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 424-429.
[3] 杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[4] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[5] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[6] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[9] 曹智, 朱希望, 王尉, 张辉, 杨成林, 张小明. 经皮肾镜碎石取石术中不同肾盂内压力与围术期并发症相关性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 616-620.
[10] 叶晋生, 路夷平, 梁燕凯, 于淼, 冀祯, 贺志坚, 张洪海, 王洁. 腹腔镜下应用生物补片修补直肠术后盆底缺损的疗效[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 688-691.
[11] 袁伟, 张修稳, 潘宏波, 章军, 王虎, 黄敏. 平片式与填充式腹股沟疝修补术的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 697-701.
[12] 夏松, 姚嗣会, 汪勇刚. 经腹腹膜前与疝环充填式疝修补术治疗腹股沟疝的对照研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 702-705.
[13] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[14] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[15] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
阅读次数
全文


摘要